Skip to main content
  • Mar 25, 2024

    Extending Treatment Durability With Next-Generation Neovascular AMD Therapies

    Course CME
    0.5 General AMA PRA Category 1 Credits™

    This course reviews the new durable anti-vascular endothelial growth factor (anti-VEGF) therapies for neovascular AMD (nAMD). Coverage includes recent data on the efficacy, safety, and durability of these new therapies, and the imaging approaches that can be used to facilitate monitoring of nAMD disease progression and treatment success.